OMX Nordic 40
|
2 358,72
|
-16,88
|
-0,71 %
|
Analysen zu OMX Nordic 40-Werten
| 02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | AstraZeneca Halten | DZ BANK | |
| 30.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 29.04.25 | Nokia Buy | Deutsche Bank AG | |
| 29.04.25 | AstraZeneca Buy | UBS AG | |
| 28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.04.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 25.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 25.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 25.04.25 | Volvo AB Outperform | RBC Capital Markets | |
| 24.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 24.04.25 | Nokia Market-Perform | Bernstein Research | |
| 24.04.25 | Volvo AB Underperform | Bernstein Research | |
| 24.04.25 | Nokia Neutral | UBS AG | |
| 24.04.25 | Volvo AB Buy | Deutsche Bank AG | |
| 24.04.25 | Nokia Underweight | Barclays Capital | |
| 24.04.25 | Nokia Hold | Jefferies & Company Inc. | |
| 23.04.25 | Volvo AB Buy | UBS AG | |
| 23.04.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 23.04.25 | Ericsson Hold | Deutsche Bank AG | |
| 23.04.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 23.04.25 | Volvo AB Outperform | RBC Capital Markets | |
| 23.04.25 | Volvo AB Underperform | Bernstein Research | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | ABB Sector Perform | RBC Capital Markets | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 22.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.